Skip to content
Search

Latest Stories

Jeremy Meader replaces Anup Sodha as Bestway Healthcare Chief Wholesale Officer

The company announces the retirement of Lexon’s co-founder, Anup Sodha

Bestway Healthcare has appointed Jeremy Meader as its new chief wholesale officer, following the retirement of Anup Sodha.


Meader would join the company in mid-November but is expected to officially assume his responsibilities from January 2, 2024.

He will lead Lexon, Bestway Medhub, Wardle’s, Knights Fragrances, PI & Specials manufacturing and the wholesale supply chain.

Sodha, who co-founded the business 25 years ago, will continue to lead the company’s wholesale business unit until 31 December 2023.

Commenting on his retirement, Sodhi said: “I am proud of what we achieved at Lexon, it has been a team effort and I am grateful to everyone who has helped as we built a strong wholesale business.

“After almost 25 years leading the business, I am delighted with the vision and passion Bestway Group have for its future and wish them every success.”

Meader comes with over 25 years of experience in wholesale from Phoenix, Alliance Healthcare and GSK.

He was the Group Sales & Marketing Director at Phoenix before he joined the independent wholesaler.

Meader expressed gratitude after joining the company, saying: “I am absolutely delighted to be joining the Bestway family and very much looking forward to getting to know the healthcare wholesale team.

“The Bestway Group has a genuine passion, commitment and vision for the UK Healthcare sector,” he added.

“I am excited to have the opportunity to lead the healthcare wholesale business unit to deliver further growth, building on the strong heritage of the combined businesses."

Bestway's CEO, Seb Hobbs, expressed his appreciation for Anup's support during the "initial integration period" and how Anup facilitated a "smooth transition" for Lexon colleagues, customers, and the brand.

“His knowledge, love for the business and its people is evident in every conversation and we are grateful for his commitment,” he said.

“We are thrilled Jeremy Meader is joining the Bestway family and excited by the contribution he will make to further develop our healthcare wholesale offer, serve more customers and grow our business.”

Earlier this year, Well Pharmacy announced the acquisition of Lexon UK Holdings and Asurex Limited.

Lexon is a family-owned business running primarily as a pharmaceutical wholesaler for 3,000 retail pharmacy customers across the UK and Ireland.

More For You

Mike Hewitson, superintendent pharmacist & managing director of Beaminster Pharmacy

Mike Hewitson elected as NPA board member for England

Mike Hewitson elected as NPA board member for England: New term begins April

Mike Hewitson, superintendent pharmacist & managing director ofBeaminster Pharmacy, has been elected as the next National Pharmacy Association (NPA) board member for England.

Since 2023, Hewitson has served as chair of Community Pharmacy Dorset. He is also a member of Somerset Council and a Non-Executive Director at HubRx.

Keep ReadingShow less
Store closures 2024: Chemists among hardest hit

Over 600 chemist shops belonging to multiples and chains were closed last year

Getty Images

35 shops closed per day last year, chemists worst affected

More shops are expected to exit the UK high streets driven by driven by rising operational costs and a continued shift towards online shopping and transactions.

According to figures from PwC, a total of 12,804 outlets operated by chains (those with five or more locations) exited high streets, shopping centres and retail parks in 2024 – equivalent to 35 closures per day.

Keep ReadingShow less
Empty pharmacy shelves due to UK medicine shortages.

The government has said it's investing up to £520m to manufacture more medicines

Pic credit: iStock

Brexit blamed for UK medicine shortages with "little sign of recovery"

The UK is facing “a worsening situation” with drugs shortages compared to the rest of Europe as a result of Brexit, according to the Nuffield Trust health thinktank.

It comes of the back of data that revealed that the department of health and social care (DHSC) received 1,938 notifications of disruptions to medicine supply last year – the highest in four years.

Keep ReadingShow less
Alert! Patients on Promixin should be switched to alternatives by 30 April

Promixin is licensed for treating chronic pulmonary infections caused by Pseudomonas aeruginosa in adults and children with cystic fibrosis

Getty Images

Medicine shortage: Promixin to be discontinued from May 2025

The Department of Health and Social Care (DHSC) and NHS England have issued a national patient safety alert regarding the upcoming shortage of Promixin (colistimethate).

The alert, issued on 17 March 2025, states that Promixin (colistimethate) 1-million-unit powder for nebuliser solution unit dose vials (UDVs) will be discontinued from early May 2025, with stocks expected to be exhausted by this time.

Keep ReadingShow less
PAGB welcomes new vice-presidents and treasurer to Board

Rob Elliott and Bas Vorsteveld ( L-R)

Bas Vorsteveld will now oversee the Kenvue’s business in Northern Europe

PAGB appoints new vice-presidents and treasurer to Board

PAGB, the consumer healthcare association, has announced the appointment of two new vice-presidents and a treasurer to their Board.

Bas Vorsteveld, area managing director for Northern Europe at Kenvue, and Rob Elliott, OTC centre of excellence lead at Viatris, have been elected as vice-presidents.

Keep ReadingShow less